These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 26273164)

  • 1. Erythrodermic Psoriasis Treated with Golimumab: A Case Report.
    Lee WK; Kim GW; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim BS
    Ann Dermatol; 2015 Aug; 27(4):446-9. PubMed ID: 26273164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two cases of Erythrodermic psoriasis treated with Golimumab.
    Kudsi M; Alzabibi MA; Shibani M
    Ann Med Surg (Lond); 2022 Jun; 78():103961. PubMed ID: 35734731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
    Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
    J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
    Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Golimumab for the treatment of psoriatic arthritis.
    Yang H; Epstein D; Bojke L; Craig D; Light K; Bruce I; Sculpher M; Woolacott N
    Health Technol Assess; 2011 May; 15 Suppl 1():87-95. PubMed ID: 21609657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Childhood psoriasis.
    Dogra S; Kaur I
    Indian J Dermatol Venereol Leprol; 2010; 76(4):357-65. PubMed ID: 20657115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Refractory Plaque-Type Psoriasis and Psoriatic Arthritis With Guselkumab and Adalimumab Combination Therapy: A Case Report.
    Rathod D; Weinberg JM; Yamauchi PS; Kircik LH; Wollina U; Lotti T; Goldust M
    J Drugs Dermatol; 2019 Apr; 18(4):394-396. PubMed ID: 31017383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advancements in the treatment of psoriasis: role of biologic agents.
    Rich SJ; Bello-Quintero CE
    J Manag Care Pharm; 2004; 10(4):318-25. PubMed ID: 15298530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study.
    Kavanaugh A; McInnes I; Mease P; Krueger GG; Gladman D; Gomez-Reino J; Papp K; Zrubek J; Mudivarthy S; Mack M; Visvanathan S; Beutler A
    Arthritis Rheum; 2009 Apr; 60(4):976-86. PubMed ID: 19333944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ustekinumab treatment of erythrodermic psoriasis occurring after physical stress: a report of two cases.
    Saraceno R; Talamonti M; Galluzzo M; Chiricozzi A; Costanzo A; Chimenti S
    Case Rep Dermatol; 2013; 5(3):254-9. PubMed ID: 24163658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological treatment for erythrodermic psoriasis.
    Dogra S; Mehta H
    Expert Opin Biol Ther; 2022 Dec; 22(12):1531-1543. PubMed ID: 36154361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulary review of 2 new biologic agents: tocilizumab for rheumatoid arthritis and ustekinumab for plaque psoriasis.
    Schafer JA; Kjesbo NK; Gleason PP
    J Manag Care Pharm; 2010; 16(6):402-16. PubMed ID: 20635831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and safety of golimumab in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under real-life clinical conditions: non-interventional GO-NICE study in Germany.
    Krüger K; Burmester GR; Wassenberg S; Bohl-Bühler M; Thomas MH
    BMJ Open; 2018 Jun; 8(6):e021082. PubMed ID: 29903793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrodermic psoriasis: pathophysiology and current treatment perspectives.
    Singh RK; Lee KM; Ucmak D; Brodsky M; Atanelov Z; Farahnik B; Abrouk M; Nakamura M; Zhu TH; Liao W
    Psoriasis (Auckl); 2016; 6():93-104. PubMed ID: 28856115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M; Joseph GJ; Princic N; Harrison DJ
    J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alefacept in the treatment of recalcitrant palmoplantar and erythrodermic psoriasis.
    Prossick TA; Belsito DV
    Cutis; 2006 Sep; 78(3):178-80. PubMed ID: 17036660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for nail psoriasis.
    de Vries AC; Bogaards NA; Hooft L; Velema M; Pasch M; Lebwohl M; Spuls PI
    Cochrane Database Syst Rev; 2013 Jan; (1):CD007633. PubMed ID: 23440816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost of biologics per treated patient across immune-mediated inflammatory disease indications in a pharmacy benefit management setting: a retrospective cohort study.
    Wu N; Lee YC; Shah N; Harrison DJ
    Clin Ther; 2014 Aug; 36(8):1231-41, 1241.e1-3. PubMed ID: 25062652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52-week, open-label, phase 3 study (UNCOVER-J).
    Saeki H; Nakagawa H; Nakajo K; Ishii T; Morisaki Y; Aoki T; Cameron GS; Osuntokun OO;
    J Dermatol; 2017 Apr; 44(4):355-362. PubMed ID: 27726163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.